Pipeline
Patient Resources
May 2025
Developing innovative therapies for the treatment of respiratory diseases
We aim to improve health and wellbeing for those affected by chronic respiratory diseases.
David Zaccardelli
President and CEO
Latest News
Verona Pharma (Nasdaq:VRNA) is focused on delivering our strategy and creating value for shareholders.
Effective October 7th, 2025, Verona Pharma Plc and it subsidiaries1 are subsidiaries of Merck & Co., Inc. (Rahway, New Jersey USA)
1 Subsidiaries include Verona Pharma, Inc. (US) and Verona Pharma Ireland Limited (Ireland).
For product-related questions, please contact us at
1-888-672-0371
Monday – Friday 8:30 AM – 5:00 PM ET
To report suspected adverse reactions, contact Verona Pharma, Inc, at
1-888-672-0371
Monday – Friday 8:30 AM – 5:00 PM ET